Pancreatic β-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4836-4841

  Bertolino, Philippe ^a,b   Tong, Wei Min ^b   Herrera, Pedro Luis ^c   Casse, Huguette ^a   Zhang, Chang Xian ^a   Wang, Zhao Qi ^b  

^a UNIVERSITÉ LYON 1   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLUCOSE; INSULIN; METHIONINE; UVOMORULIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULINOMA; LETHALITY; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 GENE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; BETA CATENIN; BLOOD GLUCOSE; CYTOSKELETAL PROTEINS; GENE DELETION; INSULIN; INSULINOMA; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS;

EID: 0042440941     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S. E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science, 276: 404-407, 1997.
2. Lemmens, I., Van de Ven, W. J., Kas, K., Zhang, C. X., Giraud, S., Wautot, V., Buisson, N., De Witte, K., Salandre, J., Lenoir, G., Pugeat, M., Calender, A., Parente, F., Quincey, D., Gaudray, P., De Wit, M. J., Lips, C. J., Hoppener, J. W., Khodaei, S., Grant, A. L., Weber, G., Kytola, S., Teh, B. T., Farnebo, F., Thakker, R. V., et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum. Mol. Genet., 6: 1177-1183, 1997.
3. Thakker, R. Multiple endocrine neoplasia type 1. In: De Groot, L. J., Besser, G., Jameson, J., Loriaux, D., Marshall, J., Odell, W., Potts, J., and Rubersteinp, A. (eds.), Endocrinology, pp. 2815-2831. Philadelphia: Saunders, 1995.
4. Agarwal, S. K., Kester, M. B., Debelenko, L. V., Heppner, C., Emmert-Buck, M. R., Skarulis, M. C., Doppman, J. L., Kim, Y. S., Lubensky, I. A., Zhuang, Z., Green, J. S., Guru, S. C., Manickam, P., Olufemi, S. E., Liotta, L. A., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet., 6: 1169-1175, 1997.
5. Giraud, S., Zhang, C. X., Serova-Sinilnikova, O., Wautot, V., Salandre, J., Buisson, N., Waterlot, C., Bauters, C., Porchet, N., Aubert, J. P., Emy, P., Cadiot, G., Delemer, B., Chabre, O., Niccoli, P., Leprat, F., Duron, F., Emperauger, B., Cougard, P., Goudet, P., Sarfati, E., Riou, J. P., Guichard, S., Rodier, M., Calender, A., et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet., 63: 455-467, 1998.
6. Farnebo, F., Teh, B. T., Kytola, S., Svensson, A., Phelan, C., Sandelin, K., Thompson, N. W., Hoog, A., Weber, G., Farnebo, L. O., and Larsson, C. Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab., 83: 2627-2630, 1998.
7. Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W. S., Agarwal, S. K., Debelenko, L. V., Kester, M., Guru, S. C., Manickam, P., Olufemi, S. E., Yu, F., Heppner, C., Crabtree, J. S., Skarulis, M. C., Venzon, D. J., Emmert-Buck, M. R., Spiegel, A. M., Chandrasekharappa, S. C., Collins, F. S., Burns, A. L., Marx, S. J., Lubensky, I. A., et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res., 57: 4682-4686, 1997.
8. Wautot, V., Vercherat, C., Lespinasse, J., Chambe, B., Lenoir, G. M., Zhang, C. X., Porchet, N., Cordier, M., Beroud, C., and Calender, A. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum. Mutat., 20: 35-47, 2002.
9. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature, 332: 85-87, 1988.
10. Debelenko, L. V., Zhuang, Z., Emmert-Buck, M. R., Chandrasekharappa, S. C., Manickam, P., Guru, S. C., Marx, S. J., Skarulis, M. C., Spiegel, A. M., Collins, F. S., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res., 57: 2238-2243, 1997.
11. Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., Spiegel, A. M., and Collins, F. S. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc. Natl. Acad. Sci. USA, 98: 1118-1123, 2001.
12. Bertolino, P., Radovanovic, I., Casse, H., Aguzzi, A., Wang, Z. X., and Zhang, C. X. Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mech. Dev., 2003, in press.
13. Biondi, C., Gartside, M., Tonks, I., Paterson, C., Hayward, N. K., and Kay, G. F. Targeting and conditional inactivation of the murine Men1 locus using the Cre recombinase: loxP system. Genesis, 32: 150-151, 2002.
14. Vidal, F., Sage, J., Cuzin, F., and Rassoulzadegan, M. Cre expression in primary spermatocytes: a tool for genetic engineering of the germ line. Mol. Reprod. Dev., 51: 274-280, 1998.
15. Herrera, P. L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development, 127: 2317-2322, 2000.
16. Tong, W. M., Cortes, U., Hande, M. P., Ohgaki, H., Cavalli, L. R., Lansdorp, P. M., Haddad, B. R., and Wang, Z. Q. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res., 62: 6990-6996, 2002.
17. Burkart, V., Wang, Z. Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., and Kolb, H. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med., 5: 314-319, 1999.
18. Herrera, P. L., Nepote, V., and Delacour, A. Pancreatic cell lineage analyses in mice. Endocrine, 2003, in press.
19. Pelengaris, S., Khan, M., and Evan, G. I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell, 109: 321-334, 2002.
20. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
21. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392: 190-193, 1998.
22. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science, 281: 1509-1512, 1998.
23. Tetsu, O., and McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon caminoma cells. Nature, 398: 422-426, 1999.
24. Hanahan, D. Heritable formation of pancreatic beta-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature, 315: 115-122, 1985.
25. Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Nowak, N., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., and Gray, J. W. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet., 29: 459-464, 2001.
26. Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., and Burns, A. L. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell, 96: 143-152, 1999.
27. Kaji, H., Canaff, L., Lebrun, J. J., Goltzman, D., and Hendy, G. N. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc. Natl. Acad. Sci. USA, 98: 3837-3842, 2001.
28. Ohkura, N., Kishi, M., Tsukada, T., and Yamaguchi, K. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochem. Biophys. Res. Commun., 282: 1206-1210, 2001.
29. Lemmens, I. H., Forsberg, L., Pannett, A. A., Meyen, E., Piehl, F., Turner, J. J., Van de Ven, W. J., Thakker, R. V., Larsson, C., and Kas, K. Menin interacts directly with the homeobox-containing protein Pem. Biochem. Biophys. Res. Commun., 286: 426-431, 2001.
30. Heppner, C., Bilimoria, K. Y., Agarwal, S. K., Kester, M., Whitty, L. J., Guru, S. C., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., and Burns, A. L. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene, 20: 4917-4925, 2001.